De Lisle Partners reports 5.9% Friedman Industries stake (FRD)
Rhea-AI Filing Summary
De Lisle Partners LLP reported beneficial ownership of 419,816 shares of Friedman Industries, Inc. common stock, representing 5.9% of the class as of the event date. The firm holds sole voting and sole dispositive power over all these shares, with no shared authority.
The filing is an amended Schedule 13G, submitted by Institutional Investment Manager Isabelle Cordwell-Riant, who serves as Head of Finance and Compliance and certifies that the applicable foreign regulatory framework is substantially comparable to the U.S. regime for similar institutions.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership did De Lisle Partners report in FRD on this Schedule 13G/A?
De Lisle Partners LLP reported beneficial ownership of 419,816 shares of Friedman Industries (FRD) common stock, equal to 5.9% of the class. All of these shares are subject to the firm’s sole voting and sole dispositive power, with no shared authority disclosed.
Who filed the amended Schedule 13G/A for Friedman Industries (FRD)?
The amended Schedule 13G/A was filed by Isabelle Cordwell-Riant, Head of Finance and Compliance. She is identified as the person filing on behalf of the institutional investment manager and certifies the accuracy of the information and the comparability of the applicable foreign regulatory framework.
What is the event date for the ownership reported in this FRD Schedule 13G/A?
The event that triggered this amended Schedule 13G filing is dated December 31, 2025. Ownership information such as the 419,816 shares and 5.9% of the class is stated as of this date, reflecting the filer’s position at that time.
How is the reporting entity classified in this Friedman Industries filing?
The reporting party is classified as an Institutional Investment Manager under the relevant SEC rules. The filer certifies that the foreign regulatory scheme applicable to this manager is substantially comparable to the U.S. regime for functionally equivalent institutions and agrees to provide additional information upon request.